ArticleJournal of virology2021

The Interleukin-33-Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine.

Clare M Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.